We have observed
6 EP applications
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after September 11, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
MODIFIED VON WILLEBRAND FACTOR
MODIFIED COAGULATION FACTORS WITH PROLONGED IN VIVO HALF-LIFE
MODIFIED VON WILLEBRAND FACTOR HAVING IMPROVED HALF-LIFE
COMPOUNDS FOR IMPROVING THE HALF-LIFE OF VON WILLEBRAND FACTOR
METHODS FOR PREPARING MODIFIED VON WILLEBRAND FACTOR
TRUNCATED VON WILLEBRAND FACTOR POLYPEPTIDES FOR TREATING HEMOPHILIA